Literature DB >> 8760944

Vero cytotoxin-producing Escherichia coli, particularly serogroup O157, associated with human infections in England and Wales: 1992-4.

A Thomas1, T Cheasty, J A Frost, H Chart, H R Smith, B Rowe.   

Abstract

Investigations were performed by the Laboratory of Enteric Pathogens on Vero cytotoxin-producing Escherichia coli (VTEC) in England and Wales from 1992-4. Bacterial isolates, faeces and sera obtained from patients with diarrhoea, bloody diarrhoea and haemolytic uraemic syndrome were examined. Using serotyping, Vero cytotoxin gene probing and serodiagnostic tests for E. coli O157, evidence of infection was detected in 543, 434 and 491 individuals in 1992, 1993 and 1994 respectively; VTEC of serogroup O157 were isolated from 470, 385 and 411 cases. The O157 VTEC strains belonged to at least 19 different phage types (PT) although 84% belonged to PT2, PT49, PT8, PT1 or PT4. Antibodies to E. coli O157 lipopolysaccharide were detected in 13% of the cases. The average annual rate of infection with O157 VTEC was 0.83/100000 and 12% of the 1458 individuals with evidence of infection with VTEC or E. coli O157 developed haemolytic uraemic syndrome. There were at least 18 general outbreaks and many family outbreaks.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8760944      PMCID: PMC2271662          DOI: 10.1017/s0950268800001060

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  21 in total

1.  Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant.

Authors:  A Thomas; H R Smith; G A Willshaw; B Rowe
Journal:  Mol Cell Probes       Date:  1991-04       Impact factor: 2.365

Review 2.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

3.  Phage-typing scheme for Escherichia coli O157:H7.

Authors:  R Ahmed; C Bopp; A Borczyk; S Kasatiya
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

4.  Untreated milk as a source of verotoxigenic E coli O157.

Authors:  P A Chapman; D J Wright; R Higgins
Journal:  Vet Rec       Date:  1993-08-14       Impact factor: 2.695

5.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Serological identification of Escherichia coli O157:H7 infection in haemolytic uraemic syndrome.

Authors:  H Chart; H R Smith; S M Scotland; B Rowe; D V Milford; C M Taylor
Journal:  Lancet       Date:  1991-01-19       Impact factor: 79.321

7.  Use of digoxigenin-labelled oligonucleotide DNA probes for VT2 and VT2 human variant genes to differentiate Vero cytotoxin-producing Escherichia coli strains of serogroup O157.

Authors:  A Thomas; H R Smith; B Rowe
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man.

Authors:  P A Chapman; C A Siddons; D J Wright; P Norman; J Fox; E Crick
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from bovine faeces.

Authors:  P A Chapman; D J Wright; C A Siddons
Journal:  J Med Microbiol       Date:  1994-06       Impact factor: 2.472

View more
  13 in total

1.  Phage types and genotypes of Shiga toxin-Producing Escherichia coli O157 in Finland.

Authors:  M Saari; T Cheasty; K Leino; A Siitonen
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Evidence of persisting serum antibodies to Escherichia coli O157 lipopolysaccharide and Verocytotoxin in members of rural communities in England.

Authors:  J Evans; R M Chalmers; H Chart; R L Salmon; S M Kench; T J Coleman; D Meadows; P Morgan-Capner; P Softley; M Sillis; D R Thomas
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

3.  Distribution of the saa gene in strains of Shiga toxin-producing Escherichia coli of human and bovine origins.

Authors:  Claire Jenkins; Neil T Perry; Tom Cheasty; Darren J Shaw; Gad Frankel; Gordon Dougan; George J Gunn; Henry R Smith; Adrienne W Paton; James C Paton
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  Application of a DNA hybridization-hydrophobic-grid membrane filter method for detection and isolation of verotoxigenic escherichia coli.

Authors:  E C Todd; R A Szabo; J M MacKenzie; A Martin; K Rahn; C Gyles; A Gao; D Alves; A J Yee
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

5.  Sporadic STEC O157 infection: secondary household transmission in Wales.

Authors:  S M Parry; R L Salmon
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

6.  Isolation of shiga toxin-producing Escherichia coli from a South American camelid (Lama guanicoe) with diarrhea.

Authors:  E C Mercado; S M Rodríguez; A M Elizondo; G Marcoppido; V Parreño
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar.

Authors:  A Lehmacher; H Meier; S Aleksic; J Bockemühl
Journal:  Appl Environ Microbiol       Date:  1998-07       Impact factor: 4.792

8.  The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012.

Authors:  L Byrne; C Jenkins; N Launders; R Elson; G K Adak
Journal:  Epidemiol Infect       Date:  2015-04-29       Impact factor: 4.434

9.  Prevalence of enteropathogenic and shiga toxin-producing Escherichia coli among children with and without diarrhoea in Iran.

Authors:  M Yousef Alikhani; Akbar Mirsalehian; Bahram Fatollahzadeh; Mohammad R Pourshafie; M Mehdi Aslani
Journal:  J Health Popul Nutr       Date:  2007-03       Impact factor: 2.000

10.  Vero cytotoxin-producing Escherichia coli O157 gastroenteritis in farm visitors, North Wales.

Authors:  Christopher J I Payne; Marko Petrovic; Richard J Roberts; Ashish Paul; Eithne Linnane; Mark Walker; David Kirby; Anthony Burgess; Robert M M Smith; Thomas Cheasty; Geraldine Willshaw; Roland L Salmon
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.